Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Lyumjev ® ▼ (insulin lispro)
Lyumjev® ▼ (insulin lispro): Stability
The shelf life for Lyumjev is 24 months before use and 28 days after first use.
The shelf life for Lyumjev is 24 months before use and 28 days after first use. 1
Lyumjev 100 units/mL solution for injection in vial
When the vial is diluted for intravenous use
Chemical, physical in-use stability has been demonstrated for 14 days at 2–8 °C and 28 hours at 20‑25 °C when protected from light. From a microbiological point of view, the medicinal product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would not normally be longer than 24 hours at 2‑8 °C, unless dilution has taken place in controlled and validated aseptic conditions.1
IL-100 = Humalog® (insulin lispro injection) 100 units/mL
Lilly = Eli Lilly and Company
URLi = ultra rapid lispro
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Date of Last Review: September 27, 2018